WESTFORD, Mass., August 5, 2013 /PRNewswire/ -- Cynosure, Inc.
(NASDAQ: CYNO) today announced that its senior management will
present at the Canaccord Genuity 33rd Annual Growth
Conference at 8:00 a.m. (ET) on
Wednesday, August 14 in Boston.
The presentation by Cynosure Chairman and Chief Executive
Officer Michael Davin and Executive
Vice President, Chief Operating Officer and Chief Financial Officer
Timothy Baker will be available via
live and archived audio webcast accessible through a link on the
Investor Relations section of the Company's website,
www.cynosure.com.
About Cynosure, Inc.
Cynosure develops and markets
aesthetic treatment systems that enable plastic surgeons,
dermatologists and other medical practitioners to perform
non-invasive and minimally invasive procedures to remove hair,
treat vascular and benign pigmented lesions, remove multi-colored
tattoos, revitalize the skin, liquefy and remove unwanted fat
through laser lipolysis, reduce cellulite, treat toe fungus and
ablate sweat glands. Cynosure's product portfolio is composed
of a broad range of energy sources including Alexandrite, diode,
Nd: YAG, picosecond, pulse dye, Q-switched lasers and intense
pulsed light. Cynosure sells its products globally under the
Cynosure, Palomar and ConBio brand names through a direct sales
force in the United States,
Canada, Mexico, France, Germany, Spain, the United
Kingdom, Australia,
China, Japan and Korea, and through international
distributors in approximately 100 other countries. For
corporate or product information, visit Cynosure's website at
www.cynosure.com.
Contact:
Scott
Solomon
Vice President
Sharon Merrill Associates, Inc.
617-542-5300
cyno@investorrelations.com
SOURCE Cynosure, Inc.